RenaissanceRe's Q3 earnings surge 53% YoY, fueled by reduced net claims and claim expenses and improved underwriting income in the Property unit, partly offset by a decline in gross premiums written.

AIT's strong Q1 results, driven by acquisitions and solid margins, prompt higher fiscal 2026 earnings guidance.

REG posts steady Q3 results, with FFO matching estimates and revenues beating estimates, backed by strong leasing and same-property NOI growth.

V's Q4 earnings and revenues top estimates as processed transactions and cross-border volumes surge despite higher costs.

CNBC's MacKenzie Sigalos reports on Microsoft's Azure and 365 outage ahead of the tech company's quarterly earnings report.

U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday said there is not enough evidence to show that Kenvue's pain medicine Tylenol definitively causes autism, but said that it should still be used cautiously in consultation with a physician.

Microsoft Azure, the cloud computing service provided by the company, is experiencing a significant outage on Wednesday. The problems started around 12 p.m.

Stepan Company ( SCL ) Q3 2025 Earnings Call October 29, 2025 9:00 AM EDT Company Participants Ruben Velasquez - VP & Chief Financial Officer Luis Rojo - President, CEO & Director Conference Call Participants Michael Harrison - Seaport Research Partners David Storms - Stonegate Capital Partners, Inc., Research Division Presentation Operator Good morning, and welcome to the Stepan Company Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded on Wednesday, October 29, 2025.

Urban Edge Properties ( UE ) Q3 2025 Earnings Call October 29, 2025 8:30 AM EDT Company Participants Areeba Ahmed - Investor Relations & ESG Associate Jeffrey Olson - Chairman & CEO Jeffrey Mooallem - Executive VP & COO Mark Langer - Executive VP & CFO Conference Call Participants Michael Goldsmith - UBS Investment Bank, Research Division Michael Griffin - Evercore ISI Institutional Equities, Research Division Floris Gerbrand Van Dijkum - Ladenburg Thalmann & Co. Inc., Research Division Michael Gorman - BTIG, LLC, Research Division Paulina Rojas-Schmidt Presentation Operator Greetings, and welcome to the Urban Edge Properties' Third Quarter 2025 …

The Boeing Company ( BA ) Q3 2025 Earnings Call October 29, 2025 10:30 AM EDT Company Participants Eric Hill - Vice President of Investor Relations Robert Ortberg - President, CEO & Director Jesus Malave - Executive VP of Finance & CFO Conference Call Participants Myles Walton - Wolfe Research, LLC Ronald Epstein - BofA Securities, Research Division Robert Stallard - Vertical Research Partners, LLC Noah Poponak - Goldman Sachs Group, Inc., Research Division Peter Arment - Robert W. Baird & Co. Incorporated, Research Division Seth Seifman - JPMorgan Chase & Co, Research Division Sheila Kahyaoglu - Jefferies LLC, Research …

Masco Corporation MAS posted lackluster third-quarter 2025 results, wherein the adjusted earnings and net sales missed the Zacks Consensus Estimate and tumbled year over year. The quarter's performance was hurt due to the weak contributions from the Decorative Architectural Products segment, which outweighed the improved performance of the Plumbing Products segment.

TeraWulf's new JV with Fluidstack boosts its HPC reach to 510 MW, improving long-term revenue visibility and prospects.

LRN's Q1 FY26 earnings and revenues top estimates, rising year over year as demand for its flexible, tech-driven education offerings strengthened.

General Motors is laying off thousands of workers across multiple electric vehicle and battery plants in the U.S., according to multiple outlets.

Fortive Corporation beat earnings expectations this morning, delivering adjusted EPS of $0.68 against a $0.57 estimate and raising full-year guidance.

Dr. Reddy's Laboratories remains a compelling buy due to underappreciated growth in biosimilars and GLP-1 segments, despite near-term headwinds. RDY's Q2 FY26 results showed modest revenue growth, with North America lagging but Europe and emerging markets offsetting declines through acquisitions and new launches. Key growth drivers include upcoming biosimilar Abatacept and generic GLP-1 drugs, with launches expected to boost earnings beyond FY27 as Revlimid headwinds subside.

Vanguard Dividend Appreciation ETF stands out for its size, liquidity, low expenses, and strong long-term performance. VIG's portfolio is heavily weighted toward Technology and Financials, which presents sector concentration risk if those areas decline. The ETF has outperformed similar dividend-focused funds in 2025 but offers a lower dividend yield compared to peers.

Shares of Albemarle NYSE: ALB, a bellwether for the lithium industry, have become a focal point for market tension. The stock recently surged 8.5% on a wave of analyst optimism, only to pivot sharply and close down 8.95% on Oct. 27 at $96.18.

AI data centers are measured in gigawatts of power these days. Wall Street analysts have been getting their arms around the cost of these beasts lately.

We pass on initiating a position in iShares 20+ Year Treasury Bond Buywrite Strategy ETF (TLTW) at this time. TLTW's covered call strategy outperforms if its underlying, TLT, remains flat. However, we expect TLT to move significantly over the next 12-24 months. Multiple factors—including likely Fed rate cuts, high US technology equity valuations, labor market and consumer confidence weakness — suggest TLT is likely to rise, not stay flat.